Skip to main content
Erschienen in: memo - Magazine of European Medical Oncology 2/2016

01.06.2016 | case report

Endometrial cancer treated with levonorgestrel-releasing intrauterine device for almost three years in an elderly woman with comorbidity

verfasst von: Lisbeth Anita Andreasen, M.D., Sofie Leisby Antonsen, M.D., Ph.D, Annette Settnes, M.D., Ph.D

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Summary

In this case report we describe the treatment of a 95-year-old woman with endometrioid adenocarcinoma. She suffered from cardiovascular comorbidity and did not want surgical treatment. Instead a levonorgestrel-releasing intrauterine device (Mirena) was inserted. She had progression of the tumor but with a minimum of symptoms and side effects. At the final examination there were no signs of extra uterine disease. The levonorgestrel-releasing intrauterine device may be an acceptable alternative to surgery in severely comorbid patients, or if the patient refuses surgical treatment.
Literatur
1.
Zurück zum Zitat Bovicelli A, D’Andrilli G, Giordano A, De Iaco P. Conservative treatment of early endometrial cancer. J Cell Physiol. 2013;228(6):1154–8. doi:10.1002/jcp.24292.CrossRefPubMed Bovicelli A, D’Andrilli G, Giordano A, De Iaco P. Conservative treatment of early endometrial cancer. J Cell Physiol. 2013;228(6):1154–8. doi:10.1002/jcp.24292.CrossRefPubMed
2.
Zurück zum Zitat Ruan X, Mueck AO. Systemic progesterone therapy – oral, vaginal, injections and even transdermal? Maturitas. 2014;79(3):248–55. doi:10.1016/j.maturitas.2014.07.009.CrossRefPubMed Ruan X, Mueck AO. Systemic progesterone therapy – oral, vaginal, injections and even transdermal? Maturitas. 2014;79(3):248–55. doi:10.1016/j.maturitas.2014.07.009.CrossRefPubMed
3.
Zurück zum Zitat Gunderson CC, Fader AN, Carson KA, Bristow RE. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012;125(2):477–82. doi:10.1016/j.ygyno.2012.01.003.CrossRefPubMed Gunderson CC, Fader AN, Carson KA, Bristow RE. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012;125(2):477–82. doi:10.1016/j.ygyno.2012.01.003.CrossRefPubMed
4.
Zurück zum Zitat Kim MK, Seong SJ, Kim YS, et al. Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer. Am J Obstet Gynecol. 2013;209(4):358.e1–358.e4. doi:10.1016/j.ajog.2013.06.031.CrossRef Kim MK, Seong SJ, Kim YS, et al. Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer. Am J Obstet Gynecol. 2013;209(4):358.e1–358.e4. doi:10.1016/j.ajog.2013.06.031.CrossRef
5.
Zurück zum Zitat Perri T, Korach J, Gotlieb WH, et al. Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved. Int J Gynecol Cancer. 2011;21(1):72–8. doi:10.1097/IGC.0b013e31820003de.CrossRefPubMed Perri T, Korach J, Gotlieb WH, et al. Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved. Int J Gynecol Cancer. 2011;21(1):72–8. doi:10.1097/IGC.0b013e31820003de.CrossRefPubMed
6.
Zurück zum Zitat Montz FJ, Bristow BE, Bovicelli A, Tomacruz R, Kurman RJ. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol. 2002;186:651–7.CrossRefPubMed Montz FJ, Bristow BE, Bovicelli A, Tomacruz R, Kurman RJ. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol. 2002;186:651–7.CrossRefPubMed
7.
Zurück zum Zitat Giannopoulos T, Butler-Manuel S, Tailor A. Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma. Gynecol Oncol. 2004;95(3):762–4.CrossRefPubMed Giannopoulos T, Butler-Manuel S, Tailor A. Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma. Gynecol Oncol. 2004;95(3):762–4.CrossRefPubMed
8.
Zurück zum Zitat Dhar KK, NeedhiRajan T, Koslowski M, Woolas RP. Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol Oncol. 2005;97(3):924–7, Jun.CrossRefPubMed Dhar KK, NeedhiRajan T, Koslowski M, Woolas RP. Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol Oncol. 2005;97(3):924–7, Jun.CrossRefPubMed
Metadaten
Titel
Endometrial cancer treated with levonorgestrel-releasing intrauterine device for almost three years in an elderly woman with comorbidity
verfasst von
Lisbeth Anita Andreasen, M.D.
Sofie Leisby Antonsen, M.D., Ph.D
Annette Settnes, M.D., Ph.D
Publikationsdatum
01.06.2016
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2016
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-016-0266-4

Weitere Artikel der Ausgabe 2/2016

memo - Magazine of European Medical Oncology 2/2016 Zur Ausgabe